Psychedelics biotech startup Entheon Biomedical announced the approval by the local Dutch ethics committee for a Phase 1 clinical trial evaluating the pharmacokinetics, pharmacodynamics and safety profile of the psychedelic compound DMT.
Category Scientific / Research
Published in Benzinga